通化东宝：首次回购约14万股

Group 1 - Company announced a share repurchase of approximately 140,000 shares, representing 0.01% of the total share capital, at a price range of 9 CNY per share, with a total transaction amount of approximately 1.29 million CNY [1] - For the first half of 2025, the company's revenue composition was 98.59% from the pharmaceutical industry, 1.27% from other businesses, and 0.14% from the real estate sector [1] - The current market capitalization of the company is 17.7 billion CNY [1]